Browse studies

Find your next paid study

1 recruiting study matching your filters

Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study

This is a double-blind, phase 2 study to evaluate safety and efficacy of rosuvastatin in comparison to placebo after 2 years in patients with compensated cirrh…

CirrhosisCirrhosis, LiverCirrhosis Early+5 more

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05832229